Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

Reynald Castaneda

20 Sep 2021

Analysis

Regulatory roundup: BMS’s T lymphocyte immunotherapy tripped by lung cancer trial termination

20 Sep 2021

17 Sep 2021

Analysis

Covid-19 mRNA vaccines for kids likely to be safe and effective but vigilance needed

17 Sep 2021

16 Sep 2021

News

CinnaGen protein subunit Covid-19 vaccine Phase III results likely within two months

16 Sep 2021

15 Sep 2021

Analysis

Telemedicine tech is yet to catch up to dermatology clinical trial demands

15 Sep 2021

13 Sep 2021

Analysis

Regulatory roundup: Ology, MaxCyte make moves in women’s cancer with divergent approval chances

13 Sep 2021

07 Sep 2021

Analysis

Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite

07 Sep 2021

02 Sep 2021

Analysis

Novavax Covid-19 vaccine booster: safety and manufacturing questions remain

02 Sep 2021

19 Aug 2021

Analysis

Single-dose J&J Covid-19 vaccine: single or double boosters, or none at all?

19 Aug 2021

17 Aug 2021

Analysis

Intercept’s NASH drug may need time to meet sky-high sales predictions if approved

17 Aug 2021

13 Aug 2021

Analysis

Trial of AbbVie’s NASH drug against severe Covid-19 enrols 25% of patients after a year

13 Aug 2021